CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells. (4th November 2015) - Morishima, Chihiro; McNeel, Douglas G; Patel, Manish R; Kohrt, Holbrook E; Waldmann, Thomas A; Thompson, John A; Conlon, Kevin C; Sondel, Paul M; Wakelee, Heather A; Apodaca, Minjun C; Fling, Steven P; Disis, Mary L; et al.